7月24日电，利弗莫尔证券显示，江苏中慧元通生物科技股份有限公司-B向港交所提交上市申请书，联席保荐人为中信证券、招银国际。

Group 1 - Livermore Securities indicates that Jiangsu Zhonghui Yuantong Biotechnology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] - The joint sponsors for the listing are CITIC Securities and CMB International [1]